Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
about
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivinDigitoxin and its analogs as novel cancer therapeuticsFirst-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meetingDigitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cellsNovel therapeutic targets for pancreatic cancerApoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaSurvivin: a unique target for tumor therapySurvivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesQuantification of cells expressing markers of proliferation and apoptosis in chronic tonsilitisAurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A ReviewTumor-derived exosomes in cancer progression and treatment failureSurvivin - The inconvenient IAPTargeting survivin in cancerLa FAM fatale: USP9X in development and diseaseInterleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivinHigh-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiformeOleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivoThe antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAILImpaired neurogenesis, learning and memory and low seizure threshold associated with loss of neural precursor cell survivin.Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression dataExamination of survivin expression in 50 chordoma specimens--A histological and in vitro study.Analysis of newly established EST databases reveals similarities between heart regeneration in newt and fish.Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factorA novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesisCancer stem cells and their mechanism of chemo-radiation resistanceSurvivin, a molecular target for therapeutic interventions in squamous cell carcinoma.The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.Caspase 2-mediated tumor suppression involves survivin gene silencing.Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.Ell3 stimulates 5-FU resistance in a breast cancer cell line.Visceral regeneration in a sea cucumber involves extensive expression of survivin and mortalin homologs in the mesothelium.Hydrogen peroxide induced genomic instability in nucleotide excision repair-deficient lymphoblastoid cellsAPOPTOSIS INDUCTION OF EPIFRIEDELINOL ON HUMAN CERVICAL CANCER CELL LINE.Potential role of caveolin-1 in acetaminophen-induced hepatotoxicityEffects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder.1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model studyInferring causal genomic alterations in breast cancer using gene expression data.
P2860
Q21195209-DA4175DE-7CE5-443A-8884-D2EEF515A07AQ21195743-AAE96230-F436-4280-BA1B-18AE258E37D3Q21198874-4195711A-69C6-44D7-AC80-0985E6B817F8Q23913664-9BB70C04-298E-4560-86D0-1CC33EFCFA64Q24564267-643F2B40-864D-4AB4-A5C7-594B0862BD6CQ26741226-3571BFE9-2294-43E2-8DE1-85D28893E165Q26747332-70805EFD-C0BA-4160-B799-C391C809F2D5Q26766250-AD7AA26C-C2AC-4E67-96E8-28F669F94CEFQ26772985-551211EE-6BCD-4043-A30A-5D9FE3427801Q26783412-9CFCB721-CFA0-40AE-93D4-EC83EC796545Q26785408-DC1DB5DB-C554-48F3-A755-94E4D37810B8Q26825700-38BEFFCC-7E25-4376-9EDA-49B7699B4593Q27012954-BD33992A-AC06-464D-A843-C03DD8E02901Q27025293-850F7A76-BD03-436F-AFFF-71101C290021Q28386284-0F8894AC-DE66-42BD-8567-0ADC3BB29EB7Q28477348-93E227B0-F0C3-44C8-BDC3-551907259915Q28477660-4192CEB4-607E-4DCE-A9DD-3380D424B10BQ28478340-E9E5F0C2-1A58-429E-8791-9AC815CEE070Q28478349-3A7EF81B-415E-4A2C-AF7D-0EA318120448Q30493022-78913B78-A3E2-4363-8AC4-A9A4249B34E9Q31095260-0963A67C-BE1E-446E-8525-8624FE042F19Q33275528-AE845395-0141-4365-B5F0-883CB2891485Q33521776-1A26907B-A4B9-4445-8765-FB7D0591A61DQ33553393-36248950-B589-421B-899C-1FF8BC0ACF51Q33597235-A1ADBD44-F105-4BEE-9B4C-1851D311A53EQ33614696-E02127D7-110D-4AF9-8D3C-E47CFCC36016Q33634679-7568C5EF-DD68-4B33-9F01-0A81BE2E83C2Q33636990-6AC58142-0C19-4239-A3BD-983C4BF41B8BQ33705936-E9DF9514-0D92-46A4-8646-BB42D1D84DA5Q33728161-2E8FFBBA-F69A-41A8-BC73-15B1B66DEDC6Q33750730-480CE28B-2EB4-462E-A46A-2E0AE86BAD92Q33757901-541288DA-D68A-41AC-831B-F6450112E16FQ33777456-105C23E9-659C-43A2-8C00-3AEF6D396FDDQ33800473-0C73D616-3B63-46FE-9FD2-71B7D5F49396Q33823766-0F5D3ABC-B982-4D9E-A3EA-0BD0B39A2F84Q33843521-33F4622E-9620-4578-ADBA-C76C084ECB47Q33843653-00C96167-EB6F-4A30-B27D-C2A26FD3AC04Q33926141-A4266049-A7B6-465E-B90D-502DB0DD2DB7Q33933202-46B0352A-67BE-4B9D-A5E7-244D22731006Q33977659-DABBC639-E0E1-4B8A-9F70-1DA239E8CA1A
P2860
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@ast
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@en
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@nl
type
label
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@ast
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@en
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@nl
prefLabel
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@ast
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@en
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@nl
P2093
P3181
P1476
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
@en
P2093
Alain C Mita
Francis J Giles
Monica M Mita
Steffan T Nawrocki
P304
P3181
P356
10.1158/1078-0432.CCR-08-0746
P407
P577
2008-08-15T00:00:00Z